All In MedTech

Device Trial Radar · NCT07919600

Effectiveness of Pulsed Electromagnetic Field Therapy in Patients With Symptomatic Plantar Calcaneal Spurs

Evaluation of the Effectiveness of Pulsed Electromagnetic Field Therapy in Patients With Symptomatic Plantar Calcaneal Spurs: A Prospective, Randomized, Sham-Controlled Trial

Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Aug 28, 2026

Primary completion

Jan 29, 2027

Study completion Jan 29, 2027

Sponsor

Lead sponsor
Hatice Zehra FERHATLARAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 5, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This prospective, randomized, sham-controlled clinical trial aims to evaluate the effectiveness of pulsed electromagnetic field (PEMF) therapy in patients with symptomatic plantar calcaneal spurs. A total of 100 participants will be randomly assigned to either an active PEMF group or a sham PEMF group in a 1:1 ratio. Both groups will receive a standardized stretching exercise program. The primary outcome will be the change in morning first-step pain intensity. Secondary outcomes will include foot function assessed using the Foot Function Index (FFI), plantar fascia thickness measured by ultrasonography, and pressure pain threshold measured using an algometer. Assessments will be performed at baseline and at weeks 4, 8, and 12 to evaluate the short- and medium-term effects of PEMF therapy.

Conditions

  • Calcaneal Spur

Interventions

  • Active Pulsed Electromagnetic Field Therapy (PEMF)Device

    Active pulsed electromagnetic field (PEMF) therapy will be administered using a BTL-4000 magnetotherapy device with a solenoid applicator. The treatment parameters will be a magnetic field intensity of 2 mT, a frequency of 50 Hz, and a session duration of 20 minutes. Treatment will be provided three times per week for four consecutive weeks, totaling 12 sessions. Participants will also receive a standardized plantar fascia and gastrocnemius-soleus stretching exercise program.

  • Sham Pulsed Electromagnetic Field Therapy (Sham PEMF)Device

    Sham PEMF treatment will be administered using the same BTL-4000 magnetotherapy device, solenoid applicator, patient positioning, and session duration as the active PEMF group, but without activation of the electromagnetic field output. Each session will last 20 minutes, three times per week for four consecutive weeks, totaling 12 sessions. Participants will also receive the same standardized plantar fascia and gastrocnemius-soleus stretching exercise program.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Morning First-Step Pain Intensity Assessed by Visual Analog Scale (VAS)Time frame: Baseline (Week 0), Week 4, Week 8, and Week 12

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Kanuni Sultan Suleyman Training and Research Hospital

    Küçükçekmece, Istanbul, Turkey (Türkiye) · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.